Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Katerzia Generic Name & Formulations
Legal Class
Rx
General Description
Amlodipine 1mg/mL; oral susp.
Pharmacological Class
Calcium channel blocker (CCB) (dihydropyridine).
How Supplied
Susp—150mL
Manufacturer
Generic Availability
NO
Katerzia Indications
Indications
Vasospastic and chronic stable angina. To reduce the risk of hospitalization for angina and to reduce the risk of a coronary revascularization procedure in recently documented coronary artery disease (CAD) and without heart failure or an ejection fraction <40%.
Katerzia Dosage and Administration
Adult
5–10mg once daily. Elderly or hepatic insufficiency: usually 5mg once daily.
Children
Not established.
Katerzia Contraindications
Not Applicable
Katerzia Boxed Warnings
Not Applicable
Katerzia Warnings/Precautions
Warnings/Precautions
Severe obstructive coronary disease. Severe aortic stenosis. CHF. Hepatic dysfunction. Pregnancy. Nursing mothers.
Katerzia Pharmacokinetics
See Literature
Katerzia Interactions
Interactions
May be potentiated by CYP3A inhibitors; monitor and may need to adjust dose. Concomitant CYP3A inducers; monitor BP. Concomitant simvastatin: limit simvastatin dose to 20mg/day. May potentiate cyclosporine or tacrolimus; monitor levels and adjust dose.
Katerzia Adverse Reactions
Adverse Reactions
Edema, fatigue, palpitations, dizziness, nausea, flushing, abdominal pain, somnolence.
Katerzia Clinical Trials
See Literature
Katerzia Note
Not Applicable
Katerzia Patient Counseling
See Literature
Katerzia Generic Name & Formulations
Legal Class
Rx
General Description
Amlodipine 1mg/mL; oral susp.
Pharmacological Class
Calcium channel blocker (CCB) (dihydropyridine).
How Supplied
Susp—150mL
Manufacturer
Generic Availability
NO
Katerzia Indications
Indications
Hypertension.
Katerzia Dosage and Administration
Adult
Initially 5mg once daily. Adjust at 7–14 day intervals; usual max 10mg once daily. Small, fragile, elderly, hepatic insufficiency, patients on other antihypertensives: initially 2.5mg once daily.
Children
<6yrs: not established. 6–17yrs: 2.5–5mg once daily.
Katerzia Contraindications
Not Applicable
Katerzia Boxed Warnings
Not Applicable
Katerzia Warnings/Precautions
Warnings/Precautions
Severe obstructive coronary disease. Severe aortic stenosis. CHF. Hepatic dysfunction. Pregnancy. Nursing mothers.
Katerzia Pharmacokinetics
See Literature
Katerzia Interactions
Interactions
May be potentiated by CYP3A inhibitors; monitor and may need to adjust dose. Concomitant CYP3A inducers; monitor BP. Concomitant simvastatin: limit simvastatin dose to 20mg/day. May potentiate cyclosporine or tacrolimus; monitor levels and adjust dose.
Katerzia Adverse Reactions
Adverse Reactions
Edema, fatigue, palpitations, dizziness, nausea, flushing, abdominal pain, somnolence.
Katerzia Clinical Trials
See Literature
Katerzia Note
Not Applicable
Katerzia Patient Counseling
See Literature
